Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-04-21FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approves a supplemental application for UROXATRAL (alfuzosin HCl) from Advanz Pharma US Corp. The approval relates to updates to the pro…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia [Phase 2]
Phase 2 trial evaluating safety and efficacy of Botulinum Toxin Type A for lower urinary tract symptoms due to benign prostatic hyperplasia …
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Prostate Mechanical Imager (PMI) Clinical Bridging Study
The clinical trial entry notes the completion of the Prostate Mechanical Imager (PMI) Clinical Bridging Study sponsored by Artann Laboratori…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients [Phase 4]
Phase 4 trial update on long-term effects of Alfuzosin (Xatral XL) in men with benign prostatic hyperplasia and lower urinary tract symptoms…
-
CLINICAL_TRIALS research · 2014-02-27Clinical Trial Update: Storage Symptom After Laser Prostatectomy
Clinical trial update concerning storage symptoms after laser prostatectomy for benign prostatic hyperplasia. The current status of the tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-02-26FDA Approved: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE — Original Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s dutasteride and tamsulosin hydrochloride combination as an original generic application. The product is indica…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer [NA]
Clinical trial update reporting MRI and MR spectroscopy imaging in men taking dutasteride for benign prostatic hyperplasia and low-risk pros…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia [NA]
This clinical trial update investigates the effect of daily tamsulosin 0.2 mg on renal function in patients with benign prostatic hyperplasi…
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) [Phase 4]
This Phase 4 exploratory trial compared PERMIXON 160 mg hard capsules (LipidoSterolic Extract of Serenoa Repens) versus Tamsulosin LP for in…
-
CLINICAL_TRIALS research · 2014-01-13Clinical Trial Update: Functional Changes of Urogenital System After Holmium Laser Prostatectomy
This clinical trial update examines functional changes in the urogenital system after holmium laser prostatectomy.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment
Completed trial assessing quality of life in men with benign prostatic hyperplasia and nocturia before and after Ocas (tamsulosin) treatment…
-
FDA approval · 2013-11-06FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin by Mylan Pharmaceuticals Inc., indicating approval of the supplemental request.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
A clinical trial investigating the urokinase plasminogen activator system for benign prostatic hyperplasia has completed.
-
FDA approval · 2013-11-05FDA Approved: FINASTERIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s FINASTERIDE as an Original Application (ANDA), authorizing the marketing of a generic FINASTERIDE pro…
-
FDA approval · 2013-11-05FDA Approved: FINASTERIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for finasteride from Aurobindo Pharma Limited, authorizing a generic version of finasteride for US mar…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia [Phase 2]
Phase 2 trial of transperineal intraprostatic injection of PRX302 under ultrasound guidance for benign prostatic hyperplasia completed with …
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate
A completed clinical study comparing outcomes of Transurethral Enucleation of Prostate (ThuLEP) versus Transurethral Resection of the Prosta…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates [NA]
Clinical trial comparing plasmakinetic enucleation of the prostate and open prostatectomy for large prostates has completed, per the sponsor…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated the effect of botulinum toxin type A on semen quality in men with benign prostatic hyperplasia; the stu…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) [Phase 3]
Phase 3 study of once-daily tadalafil in Asian men with benign prostatic hyperplasia has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia [NA]
A University of Illinois at Chicago-led trial investigating lycopene for prostate cancer and benign prostatic hyperplasia has completed.
-
FDA approval · 2013-09-10FDA Approved: AVODART — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for AVODART (dutasteride) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) [Phase 1, Phase 2]
Clinical trial update shows Phase 1/2 testing of PRX302 for lower urinary tract symptoms due to benign prostatic hyperplasia has completed.
-
FDA approval · 2013-07-01FDA Approved: FINASTERIDE — Original Application (Dr Reddys Laboratories Inc)
The FDA approved a generic FINASTERIDE product from Dr Reddys Laboratories Inc under an original ANDA.
-
FDA approval · 2013-07-01FDA Approved: FINASTERIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' generic finasteride under an original application (ANDA 090508), with indications including beni…